Company profile
Orion Corporation
Diversified pharma; originator of levosimendan
ORNBV · Nasdaq Helsinki · Finland
Public Market Listing
ORNBVNasdaq Helsinki
Live quotes, historical charts, and market capitalization for Orion Corporation are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
2Total Assets
1Approved
1Phase 3 / Filed
0Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
entacapone(Comtess) | Approved | COMTSmall molecule | Parkinson's Disease |
Levosimendan(Simdax) | Phase 3 | Cardiac troponin C (calcium sensitizer)Small molecule | HypertensionHeart Failure Pulmonary Hypertension |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.